Q32 Bio (QTTB) Non-Current Deferred Revenue (2017 - 2022)
Q32 Bio (QTTB) posted Non-Current Deffered Revenue of $354,000 for Q1 2022, down 90.1% from $3.56 million a year earlier and down 69.4% from the prior quarter.
Powered by 
Analysis
Q32 Bio (QTTB) Non-Current Deferred Revenue (2017 - 2022) Analysis & Trends
At the end of FY2021, Q32 Bio's Non-Current Deffered Revenue came in at $1.16 million, down 96.4% from FY2020.
- Annual Non-Current Deffered Revenue shows a four-year compound annual growth rate of -55.7% (FY2017 to FY2021).
- In prior years, Q32 Bio's Non-Current Deffered Revenue was $32.14 million in FY2020 (+6.6%), $30.14 million in FY2019 (-2.0%), $30.75 million in FY2018 (+2.3%) and $30.07 million in FY2017.
- The Q1 2022 figure stands as the lowest quarterly Non-Current Deffered Revenue in data going back to Q4 2017.
- On a year-over-year basis, Non-Current Deffered Revenue has declined in each of the last five quarters, with an average decline of 58.0% over the last eight quarters.
- The strongest year-over-year quarter for Non-Current Deffered Revenue in the past five years was Q4 2020, with growth of 6.6%; the weakest was Q4 2021, with a decline of 96.4%.
- According to Business Quant data, Non-Current Deffered Revenue for the three prior quarters was $1.16 million (Q4 2021), $1.96 million (Q3 2021) and $2.76 million (Q2 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Q32 Bio | 278.89 Mn | -235.96 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 354,000.00 |
| Dec 31, 2021 | 1.16 Mn |
| Sep 30, 2021 | 1.96 Mn |
| Jun 30, 2021 | 2.76 Mn |
| Mar 31, 2021 | 3.56 Mn |
| Dec 31, 2020 | 32.14 Mn |
| Sep 30, 2020 | 27.42 Mn |
| Jun 30, 2020 | 29.78 Mn |
| Mar 31, 2020 | 29.97 Mn |
| Dec 31, 2019 | 30.14 Mn |
| Sep 30, 2019 | 30.37 Mn |
| Jun 30, 2019 | 30.60 Mn |
| Mar 31, 2019 | 30.52 Mn |
| Dec 31, 2018 | 30.75 Mn |
| Sep 30, 2018 | 29.74 Mn |
| Jun 30, 2018 | 29.75 Mn |
| Mar 31, 2018 | 29.85 Mn |
| Dec 31, 2017 | 30.07 Mn |
API Access
Q32 Bio Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=QTTB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "QTTB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=QTTB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();